Cargando…
Ex vivo assessment of targeted therapies in a rare metastatic epithelial–myoepithelial carcinoma
Epithelial–myoepithelial carcinoma (EMC) is a rare subtype of salivary gland neoplasms. Since the initial description of the cancer, just over 300 cases have been reported. EMCs occupy a biphasic cellular differentiation-state defined by the constitution of two cell types representing epithelial and...
Autores principales: | Mäkelä, Rami, Arjonen, Antti, Suryo Rahmanto, Aldwin, Härmä, Ville, Lehtiö, Janne, Kuopio, Teijo, Helleday, Thomas, Sangfelt, Olle, Kononen, Juha, Rantala, Juha K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341452/ https://www.ncbi.nlm.nih.gov/pubmed/32645560 http://dx.doi.org/10.1016/j.neo.2020.06.007 |
Ejemplares similares
-
Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinoma
por: Mäkelä, Rami, et al.
Publicado: (2020) -
Ex Vivo Drug Screening Informed Targeted Therapy for Metastatic Parotid Squamous Cell Carcinoma
por: Nykänen, Noora, et al.
Publicado: (2021) -
Ex vivo analysis of DNA repair targeting in extreme rare cutaneous apocrine sweat gland carcinoma
por: Mäkelä, Rami, et al.
Publicado: (2021) -
PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer
por: Brunner, Andrä, et al.
Publicado: (2020) -
K63-linked ubiquitylation induces global sequestration of mitochondria
por: Richard, Thibaud J. C., et al.
Publicado: (2020)